date,title,source
Oct-19-18,"Curis (CRIS) Shares March Higher, Can It Continue?",Zacks
Oct-23-18,"Curis to Release Third Quarter Financial Results and Hold Conference Call on November 1, 2018",PR Newswire
Oct-23-18,"Investor Expectations to Drive Momentum within Ormat Technologies, The Andersons, Freshpet, Curis, Ultra Clean, and Edge Therapeutics  Discovering Underlying Factors of Influence",GlobeNewswire
Nov-01-18,"Curis (CRIS) Reports Q3 Loss, Tops Revenue Estimates",Zacks
Nov-01-18,Curis: 3Q Earnings Snapshot,Associated Press
Nov-01-18,Curis Reports Third Quarter 2018 Financial Results,PR Newswire
Nov-05-18,Edited Transcript of CRIS earnings conference call or presentation 1-Nov-18 12:30pm GMT,Thomson Reuters StreetEvents
Nov-07-18,Curis to Present at 33rd Society for Immunotherapy of Cancer Annual Meeting and Cowen IO NEXT Summit,PR Newswire
Nov-20-18,Curis to Present at the 60th Annual Meeting of the American Society of Hematology,PR Newswire
Nov-30-18,"Analysis: Positioning to Benefit within Dicerna Pharmaceuticals, Sun Life Financial, Autodesk, Eagle Pharmaceuticals, Curis, and Accenture  Research Highlights Growth, Revenue, and Consolidated Results",GlobeNewswire
Jan-04-19,Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),PR Newswire
Jan-08-19,Top 3 Healthcare Penny Stocks for 2018,Investopedia
Jan-10-19,First Eagle Slashes Curis Stake at Substantial Loss,GuruFocus.com
Jan-10-19,Is Curis (CRIS) Outperforming Other Medical Stocks This Year?,Zacks
Jan-24-19,First Mesothelioma Patient Dosed in CA-170 Study,PR Newswire
Jan-29-19,Has Curis (CRIS) Outpaced Other Medical Stocks This Year?,Zacks
Feb-04-19,"Curis, Inc. to Present at the 2019 BIO CEO & Investor Conference",PR Newswire
Mar-04-19,Curis Announces Presentation at Cowen & Company 39th Annual Healthcare Conference,PR Newswire
Mar-25-19,What's Driving The Rally In Microcap Biotech Curis?,Benzinga
Mar-25-19,Biotech News: Why Curis Stock Is Soaring Today,InvestorPlace
Mar-25-19,Curis' stock rockets on heavy volume after $135.7 million deal to sell portion of Erivedge royalties,MarketWatch
Mar-25-19,Curis Sells Portion of Erivedge Royalties to Oberland Capital for up to $135.7 million,PR Newswire
Mar-25-19,"Curis to Release Fourth Quarter and Year-End 2018 Financial Results and Host Conference Call on March 26, 2019",PR Newswire
Mar-26-19,Curis: 4Q Earnings Snapshot,Associated Press
Mar-26-19,Curis Reports Fourth Quarter and Year-End 2018 Financial Results,PR Newswire
Mar-26-19,"The Daily Biotech Pulse: Japanese Cheer For AbbVie, Myokardia Offering, CytomX CFO Departs",Benzinga
Mar-27-19,Edited Transcript of CRIS earnings conference call or presentation 26-Mar-19 8:30pm GMT,Thomson Reuters StreetEvents
Apr-05-19,Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),PR Newswire
